nad has been researched along with epirubicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, J; Li, X; Liang, X; Liu, Y; Yalamarty, SSK; Zhang, J; Zhang, P; Zheng, Q; Zhou, X; Zou, Q | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
2 other study(ies) available for nad and epirubicin
| Article | Year |
|---|---|
Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer.
Topics: Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Cell Survival; Epirubicin; Female; Humans; Hyperthermia, Induced; Indoles; Lasers; Mice, Inbred BALB C; NAD; Nanoparticles; Neoplasms, Experimental; Particle Size; Phototherapy; Polymers; Rats, Sprague-Dawley; Reactive Oxygen Species; Temperature; Tissue Distribution; Triple Negative Breast Neoplasms | 2020 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |